Amgen restructures amid setbacks, cutting around 40 jobs
SOURCENews reportView the filing ↗
What we know
Based on news reporting.
Summary
Amgen Inc. is implementing a restructuring that has resulted in the elimination of around 40 jobs. The company is reorganizing while facing regulatory pressure related to a rare-disease drug and several disappointing research results. A spokesperson declined to specify which parts of Amgen would be affected by the layoffs. The report frames the cuts as part of broader strategic changes at the biotech firm.
Amgen Inc. cut 40 jobs.
That is roughly 0.1% of the 26,700 people Amgen Inc. employs.
LayoffTalk has tracked 5 layoff events at Amgen Inc. since December 2022, including 736 jobs documented in official WARN filings, with 1 additional event known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Amgen Inc.
Recent tracked events at this company.